Table 3.
Risk factors associated with infectious complications in our cohort.
| Infection | p-value | ||
|---|---|---|---|
| (+) N=11 | (−) N=28 | ||
| Male gender, n (%) | 2 (18.2%) | 10 (35.7%) | 0.28 |
| Age >65 years, n (%) | 6 (54.5%) | 13 (46.4%) | 0.65 |
| BMI>30, n (%) | 1 (9.1%) | 2 (7.1%) | 0.84 |
| Diabetes Mellitus, n (%) | 0 (0%) | 11 (39.3%) | 0.01 |
| Coronary Artery Disease, n (%) | 1 (9.1%) | 3 (10.7%) | 0.88 |
| Malignancy, n (%) | 1(9.1%) | 4 (14.3%) | 0.66 |
| Radiologic pattern, n (%) | |||
| UIP | 0 (%) | 10 (35.7%) | 0.02 |
| Non-UIP | 11 (100%) | 18 (64.3%) | |
| LTOT, n (%) | 1 (9.1%) | 1 (3.7%) | 0.5 |
| Initial Prednisolone dose (mg/d), mean (SD) | 20 (±16.4) | 26.3 (±18.5) | 0.3 |
| Baseline DLCO, mean (SD) | 54.2% (±18.1) | 46.7% (±14.9) | 0.2 |
| Baseline FVC, mean (SD) | 72.6% (±15.83) | 81.4% (±19.5) | 0.18 |